Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Almost all anesthesiologists report drug shortages

Anesthesiologists Report Drug Shortages Impacting Patient Care

0
Survey finds that 98 percent of respondents report experiencing drug shortages on a consistent basis
The U.S. Drug Enforcement Administration and local agencies are holding the 15th National Prescription Drug Take Back Day across the country this Saturday

Saturday Is National Prescription Drug Take Back Day

0
Unused medications can be dropped off at local collection sites between 10 a.m. and 2 p.m.
For patients with ischemic stroke

Tenecteplase Appears Superior to Alteplase After Ischemic Stroke

0
Tenecteplase within 4.5 hours after symptoms linked to higher reperfusion, better functional outcomes
For children with neuronal ceroid lipofuscinosis type 2 disease

AAN: Cerliponase Alfa Beneficial for Form of Batten’s Disease

0
Reduced decline in motor, language function in children with CLN2 compared with historical controls
Serlopitant has potential as a therapy for the treatment of chronic pruritus

Serlopitant Found to Be Safe, Effective for Chronic Pruritus

0
Findings show a dose-dependent response in decrease in itchiness
Guidelines have been developed for use of disease-modifying therapies in multiple sclerosis

Guidelines Developed for Use of Drugs in Multiple Sclerosis

0
Guidelines relate to starting, switching, stopping disease-modifying therapies
A smartphone app is associated with improved short-term adherence to a cutaneous foam treatment for psoriasis

Phone App Linked to Improved Psoriasis Treatment Adherence

0
App intervention group also had greater reduction in psoriasis severity than non-intervention group
Although most adults with epilepsy report taking epilepsy medication

Too Few Adults Taking Epilepsy Meds Have Seizure Control

0
Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control
Weekly belimumab is associated with greater benefit than placebo for patients with hypocomplementemic/anti-double stranded DNA-positive systemic lupus erythematosus

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

0
More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group
For patients with episodic migraine who have failed prior preventive migraine treatments

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

0
Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days